Honoring National Gray Day: Advancing Brain Cancer Awareness and Research

Today marks National Gray Day, a powerful observance during Brain Cancer Awareness Month dedicated to honoring the lives lost to brain cancer and standing in solidarity with patients, survivors, and their families who continue to face this devastating disease.

Founded by Voices Against Brain Cancer, National Gray Day serves as a national call to action to raise awareness, support ongoing research, and inspire hope for a cure.

At Plus Therapeutics, we are proud to stand with the dedicated patient advocacy organizations leading the charge in awareness and education, including:

  • National Brain Tumor Society
  • Brain Tumor Network
  • Glioblastoma Research Organization
  • American Brain Tumor Association
  • And many more champions in the fight against brain tumors

Advancing Hope Through Clinical Research: The RESPECT-GBM Trial

As part of our ongoing commitment to oncology innovation, Plus Therapeutics is currently enrolling patients in the RESPECT-GBM Phase 2 clinical trial, focused on developing new treatment options for glioblastoma (GBM)—one of the most aggressive and difficult-to-treat forms of brain cancer.

If you or a loved one may qualify for participation, please visit: respect-trials.com/gbm
Or contact our team directly at respect@plustherapeutics.com.

Together, through awareness, advocacy, and clinical research, we can advance toward a future with better outcomes and one day, a cure.

#NationalGrayDay #BrainCancerAwarenessMonth #BrainCancer #Glioblastoma #GBM #ClinicalTrials #RESPECTGBM #CancerResearch #Oncology #GrayMay #GoGrayInMay #BTAM #BrainTumorStrong #PSTV #PatientAdvocacy #BrainTumorAwareness